{
    "summary": "This bill, the 340B PATIENTS Act of 2025, aims to ensure accessibility of discounted drugs under the 340B program. It clarifies that drug manufacturers must offer discounted pricing regardless of where the drug is dispensed, including through contract pharmacies. The bill prohibits manufacturers from placing conditions on covered entities' ability to purchase and use these drugs and institutes civil monetary penalties for violations. It also mandates regulations to enable covered entities to report violations.",
    "tags": [
        "Healthcare access",
        "Consumer protection",
        "Healthcare",
        "Opioid crisis",
        "Transparency"
    ],
    "category": "Healthcare & Public Health"
}